1,560 Shares in Teleflex Incorporated (TFX) Acquired by Meiji Yasuda Life Insurance Co

Meiji Yasuda Life Insurance Co acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX) during the first quarter, Holdings Channel reports. The fund acquired 1,560 shares of the medical technology company’s stock, valued at approximately $302,000.

Several other hedge funds also recently made changes to their positions in the stock. Asset Planning Services Ltd. bought a new stake in shares of Teleflex during the first quarter valued at about $116,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in shares of Teleflex during the first quarter worth $155,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Teleflex by 14.5% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,267 shares of the medical technology company’s stock worth $213,000 after buying an additional 160 shares during the period. Mn Services Vermogensbeheer B.V. boosted its stake in shares of Teleflex by 3.1% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 1,175 shares of the medical technology company’s stock worth $213,000 after buying an additional 35 shares during the period. Finally, Independence Advisors LLC acquired a new stake in shares of Teleflex during the first quarter worth $215,000. 93.02% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Shares of Teleflex Incorporated (NYSE:TFX) traded up 1.60% during trading on Friday, reaching $196.59. 163,506 shares of the company’s stock were exchanged. The company has a 50 day moving average of $198.07 and a 200 day moving average of $176.00. The firm has a market capitalization of $8.84 billion, a P/E ratio of 40.80 and a beta of 0.93. Teleflex Incorporated has a 52-week low of $136.53 and a 52-week high of $211.22.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 4th. The medical technology company reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.69 by $0.11. Teleflex had a net margin of 15.09% and a return on equity of 15.66%. The business had revenue of $487.90 million for the quarter, compared to analyst estimates of $472.81 million. During the same period last year, the business posted $1.52 EPS. Teleflex’s revenue was up 14.8% compared to the same quarter last year. Equities analysts anticipate that Teleflex Incorporated will post $8.16 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 15th. Shareholders of record on Monday, May 15th will be given a $0.34 dividend. The ex-dividend date of this dividend is Thursday, May 11th. This represents a $1.36 annualized dividend and a yield of 0.70%. Teleflex’s dividend payout ratio is 23.49%.

ILLEGAL ACTIVITY WARNING: “1,560 Shares in Teleflex Incorporated (TFX) Acquired by Meiji Yasuda Life Insurance Co” was published by Mideast Time and is the sole property of of Mideast Time. If you are accessing this story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark law. The original version of this story can be accessed at https://www.mideasttime.com/1560-shares-in-teleflex-incorporated-tfx-acquired-by-meiji-yasuda-life-insurance-co/1708733.html.

A number of analysts recently weighed in on TFX shares. Leerink Swann upped their price target on shares of Teleflex from $151.00 to $177.00 and gave the stock a “market perform” rating in a research report on Monday, February 13th. Stephens raised shares of Teleflex from an “equal weight” rating to an “overweight” rating in a research report on Friday, February 24th. Barclays PLC reaffirmed a “buy” rating and set a $205.00 price target on shares of Teleflex in a research report on Wednesday, March 1st. Needham & Company LLC started coverage on shares of Teleflex in a research report on Monday, March 6th. They set a “buy” rating and a $221.00 price target for the company. Finally, Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $217.00 price target for the company in a research report on Tuesday, March 14th. Two investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $208.00.

In other Teleflex news, VP John Deren sold 2,246 shares of the firm’s stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $194.07, for a total value of $435,881.22. Following the sale, the vice president now directly owns 3,989 shares in the company, valued at approximately $774,145.23. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stephen K. M.D. Klasko sold 5,200 shares of the firm’s stock in a transaction on Monday, May 15th. The stock was sold at an average price of $193.56, for a total transaction of $1,006,512.00. Following the completion of the sale, the director now owns 12,880 shares in the company, valued at $2,493,052.80. The disclosure for this sale can be found here. Company insiders own 2.15% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

5 Day Chart for NYSE:TFX

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.